Healthy Living/WellnessAmarin Wins 'Off-Label' Drug Promotion Court Battle Against FDA A federal court ruled that the FDA could not prohibit Amarin Corp. from marketing its Vascepa drug for off-label use. The court says that doing so would be a violation of free speech.by Rhodi Lee
Healthy Living/WellnessFrances Oldham Kelsey, Who Saved The U.S. From Thalidomide Disaster, Dies At 101by James Maynard
Healthy Living/WellnessEPA Accidentally Spills 1 Million Gallons Of Wastewater From Colorado Mine: What To Knowby Jill Arce
Healthy Living/WellnessStudy Says England Is Lagging Behind When It Comes To Cancer Survivalby Dianne Depra
Healthy Living/WellnessShorter Course Of Radiation Therapy Results To Better Quality Of Life In Early Stage Breast Cancer Patientsby Rina Marie Doctor
Healthy Living/WellnessRipped Body Over Health? Some Men Replace Meals With Bodybuilding Supplementsby Rhodi Lee
Healthy Living/WellnessIBM Acquires Merge Healthcare To Upgrade Watson Medical Capabilitiesby Ted Ranosa